Hydrocortisone Sodium Succinate Injection
Product Images NDC 69097-004

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrocortisone Sodium Succinate (NDC 69097-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (16d10e93 05c2 464a Bf84 10118a8964c7 01)

Chemical structure of Hydrocortisone sodium succinate shown as a 2D molecular diagram with labeled functional groups and bonds.*

FDA Label Image

Carton-label (Carton Label)

Packaging label for Hydrocortisone Sodium Succinate Injection, USP 100 mg/2 mL vial by Cipla USA Inc. The label states it is preservative-free, for intramuscular or intravenous use, and is a single-dose vial. Instructions include storage temperature, usage directions, and manufacturer information with a barcode and NDC 69097-004.*

FDA Label Image

Vial-label (Vial Label)

Label for Hydrocortisone Sodium Succinate injection, USP, 100 mg per vial, manufactured by Cipla USA Inc. The single-dose vial is preservative-free and intended for intramuscular or intravenous use. The label includes dosage instructions, storage precautions, manufacturer details, and batch information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.